Weihua Lou

Shanghai Jiaotong University 1630 Dong Fang Rd
Dongfang, 200127, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Hepatoid Carcinoma of the Ovary: Case Report, Clinical Management, and Insights From Literature Review.

Hepatoid Carcinoma of the Ovary: Case Report, Clinical Management, and Insights From Literature Review.

Journal: Clinical case reports
Published: August 08, 2025

EPI-SauriCas9-based mouse ovarian cancer models recapitulating pten deletion in patients.

EPI-SauriCas9-based mouse ovarian cancer models recapitulating pten deletion in patients.

Journal: Communications biology
Published: April 09, 2025

[68Ga]Ga-FAPI-04 PET/MR imaging strategy in management of Krukenberg tumors (KTs) from gastric signet-ring-cell carcinoma: to overcome limitation of [68Ga]Ga-FAPI-04 PET imaging in KTs.

[68Ga]Ga-FAPI-04 PET/MR imaging strategy in management of Krukenberg tumors (KTs) from gastric signet-ring-cell carcinoma: to overcome limitation of [68Ga]Ga-FAPI-04 PET imaging in KTs.

Journal: European journal of nuclear medicine and molecular imaging
Published: February 27, 2024

The efficacy of immune checkpoint inhibitors on low PD-L1 cervical cancer: A meta-analysis.

The efficacy of immune checkpoint inhibitors on low PD-L1 cervical cancer: A meta-analysis.

Journal: Health science reports
Published: November 19, 2023

Comparative evaluation of antitumor effects of TNF superfamily costimulatory ligands delivered by mesenchymal stem cells.

Comparative evaluation of antitumor effects of TNF superfamily costimulatory ligands delivered by mesenchymal stem cells.

Journal: International immunopharmacology
Published: August 16, 2023

Case Series of Diabetic Ketoacidosis in Late Pregnancy with Normal Glucose Tolerance.

Case Series of Diabetic Ketoacidosis in Late Pregnancy with Normal Glucose Tolerance.

Journal: International journal of women's health
Published: July 31, 2023

A multicenter noninferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stage IB3 and IIA2): study protocol of the LAUNCH 3 trial.

A multicenter noninferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stage IB3 and IIA2): study protocol of the LAUNCH 3 trial.

Journal: Trials
Published: August 18, 2022

Aggressive Gliomatosis Peritonei Arising from Ovarian Mature Teratoma with NF1 Mutation: A Case Report and Literature Review.

Aggressive Gliomatosis Peritonei Arising from Ovarian Mature Teratoma with NF1 Mutation: A Case Report and Literature Review.

Journal: Cancer management and research
Published: May 31, 2022

A multicenter non-inferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stages IB1, IB2, and IIA1): study protocol of the LAUNCH 2 trial.

A multicenter non-inferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stages IB1, IB2, and IIA1): study protocol of the LAUNCH 2 trial.

Journal: Trials
Published: January 26, 2022

A multicenter noninferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stage IA1 with LVSI, IA2): study protocol of the LAUNCH 1 trial.

A multicenter noninferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stage IA1 with LVSI, IA2): study protocol of the LAUNCH 1 trial.

Journal: BMC cancer
Published: January 20, 2022

FBXO22 Promotes Growth and Metastasis and Inhibits Autophagy in Epithelial Ovarian Cancers via the MAPK/ERK Pathway.

FBXO22 Promotes Growth and Metastasis and Inhibits Autophagy in Epithelial Ovarian Cancers via the MAPK/ERK Pathway.

Journal: Frontiers in pharmacology
Published: September 17, 2021

Serum immunoglobulin G N-glycome: a potential biomarker in endometrial cancer.

Serum immunoglobulin G N-glycome: a potential biomarker in endometrial cancer.

Journal: Annals of translational medicine
Published: July 11, 2020
Showing 1-12 of 19

Last Updated: 09/26/2026